TP53

The biology of hypomorphic TP53 variants and implications for clinical management.

Syndrome de Li-Fraumeni / variants hypomorphes de TP53

Performance of LFSPRO prediction in TP53 mutation status for prospectively collected probands.

Syndrome de Li-Fraumeni (SLF) — prédisposition héréditaire aux cancers multiples précoces liée à TP53

A zero-parameter framework for accurate TP53 missense variant functional classification.

Classification fonctionnelle des variants missense *TP53* / Syndrome de Li-Fraumeni

A zero-parameter first-principles gate framework for full-length TP53 missense variant interpretation

Classification des variants faux-sens de *TP53* — approche premiers principes

Clinical and surveillance outcomes of the TP53 c.1000G > C (p.Gly334Arg) variant.

Syndrome de Li-Fraumeni atténué — variant TP53 p.Gly334Arg

Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53).

Syndrome de Li-Fraumeni

European Colonial Echoes in Cancer Risk: Lessons from the TP53 p.R337H Founder Variant in Brazil

Syndrome de Li-Fraumeni (atténué) — prédisposition pan-cancéreuse

Interpreting TP53 pathogenic variants: diagnostic complexities of mosaic and germline variants.

Syndrome de Li-Fraumeni / variants TP53 mosaïques

Genotypic and phenotypic characteristics of germline TP53 variant carriers: experience from two cancer genetic counseling units.

Syndrome de Li-Fraumeni

Missense but mis-spliced: germline TP53 variant c.671A > C (p.E224A) and the path from uncertainty to pathogenicity.

Syndrome de Li-Fraumeni

Proton therapy in young breast cancer patients with germline TP53 and ATM mutations: a case series.

Cancer du sein — protonthérapie chez les porteuses de mutations germinales TP53 et ATM

Clinical characteristics and management of Li-Fraumeni syndrome-associated lung cancer.

Adénocarcinome pulmonaire au cours du syndrome de Li-Fraumeni